These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26134026)

  • 1. [T-cell prolymphocytic leukemia treated with alemtuzumab and followed by autologous hematopoietic stem cell transplantation: a case report].
    Chen M; Zhang L; Jia Y; Liu F; Li J; Zhang D; Zhang L; Pan L
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):536. PubMed ID: 26134026
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center Experience.
    Damlaj M; Sulai NH; Oliveira JL; Ketterling RP; Hashmi S; Witzig T; Nowakowski G; Call TG; Shanafelt TD; Ding W; Hogan WJ; Litzow MR; Patnaik MM
    Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):699-704. PubMed ID: 26422251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study.
    Krishnan B; Else M; Tjonnfjord GE; Cazin B; Carney D; Carter J; Ketterer N; Catovsky D; Ethell M; Matutes E; Dearden CE
    Br J Haematol; 2010 Jun; 149(6):907-10. PubMed ID: 20201944
    [No Abstract]   [Full Text] [Related]  

  • 4. Are we improving the outcome for patients with T-cell prolymphocytic leukemia by allogeneic stem cell transplantation?
    Herling M
    Eur J Haematol; 2015 Mar; 94(3):191-2. PubMed ID: 25712069
    [No Abstract]   [Full Text] [Related]  

  • 5. [Successful Treatment of T-Cell Prolymphocytic Leukemia with Alemtuzumab].
    Ueki D; Yoshida C; Tsutsumi Oota I; Seki M; Komeno T; Ito H; Ide Y
    Gan To Kagaku Ryoho; 2019 May; 46(5):913-915. PubMed ID: 31189814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell prolymphocytic leukemia.
    Khot A; Dearden C
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):365-71. PubMed ID: 19275513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation in T-cell prolymphocytic leukemia: A single-center experience.
    Dholaria BR; Ayala E; Sokol L; Nishihori T; Chavez JC; Hussaini M; Kumar A; Kharfan-Dabaja MA
    Leuk Res; 2018 Apr; 67():1-5. PubMed ID: 29407180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation].
    Momose H; Kurita N; Nishikii H; Yusa N; Yokoyama K; Shimizu E; Imoto S; Nanmoku T; Maruyama Y; Sakamoto T; Yokoyama Y; Kato T; Matsuoka R; Obara N; Sakata-Yanagimoto M; Chiba S
    Rinsho Ketsueki; 2024; 65(1):35-40. PubMed ID: 38311387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I treat prolymphocytic leukemia.
    Dearden C
    Blood; 2012 Jul; 120(3):538-51. PubMed ID: 22649104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B and T cell prolymphocytic leukaemia.
    Cross M; Dearden C
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):217-228. PubMed ID: 31585622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary vasculitis associated with T-cell prolymphocytic leukemia.
    Audemard A; Boutemy J; Guilpain P; Sabatier R; Silva NM; Bienvenu B
    Joint Bone Spine; 2014 Jan; 81(1):93-4. PubMed ID: 23731632
    [No Abstract]   [Full Text] [Related]  

  • 12. A pediatric case of T-cell prolymphocytic leukemia.
    Mitton B; Coutre S; Willert J; Schlis K; Porteus M; Kharbanda S; Agarwal-Hashmi R
    Pediatr Blood Cancer; 2015 Jun; 62(6):1061-2. PubMed ID: 25417638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation.
    Yamasaki S; Nitta H; Kondo E; Uchida N; Miyazaki T; Ishiyama K; Kiyota M; Matsuoka H; Ichinohe T; Fukuda T; Atsuta Y; Suzumiya J; Suzuki R
    Ann Hematol; 2019 Sep; 98(9):2213-2220. PubMed ID: 31327025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell Prolymphocytic Leukemia.
    Sud A; Dearden C
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):273-283. PubMed ID: 28340878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary refractory T-cell prolymphocytic leukaemia treated with daily administration of Alemtuzumab plus high-dose methylprednisolone.
    Renaudon-Smith E; Gribben JG; Agrawal SG
    Eur J Haematol; 2014 Apr; 92(4):360-1. PubMed ID: 24329558
    [No Abstract]   [Full Text] [Related]  

  • 16. Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
    Drozd-Sokolowska J; Gras L; Koster L; Martino R; Salas MQ; Salmenniemi U; Zudaire T; Yañez L; Bellido M; Collin M; Kaufmann M; Kozlowski P; Poiré X; Ferra C; Sampol A; Wilson KMO; Cairoli A; Gedde-Dahl T; Deconinck E; Mirabile M; Suarez F; Raj K; Van Gelder M; Yakoub-Agha I; Tournilhac O; McLornan DP
    Haematologica; 2024 May; 109(5):1608-1613. PubMed ID: 38205539
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
    Hopfinger G; Busch R; Pflug N; Weit N; Westermann A; Fink AM; Cramer P; Reinart N; Winkler D; Fingerle-Rowson G; Stilgenbauer S; Döhner H; Kandler G; Eichhorst B; Hallek M; Herling M
    Cancer; 2013 Jun; 119(12):2258-67. PubMed ID: 23512246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell prolymphocytic leukemia.
    Dearden CE
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S239-43. PubMed ID: 19778847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of alemtuzumab in nonmyeloablative hematopoietic transplantation.
    Giralt S
    Semin Oncol; 2006 Apr; 33(2 Suppl 5):S36-43. PubMed ID: 16720202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
    Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.